Shu-Lang Liao

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 6

Top Topics

Minimally Invasive

Top Venues

Eye (London, England)

Oxidative medicine and cellular longevity

Japanese journal of ophthalmology

BioMed research international

National Taiwan University Hospital

National Taiwan University (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Taiwan University Hospital Jul 01 1990

Taiwan

Visting Staff :: Department of Ophthalmology

Education History

National Taiwan University Sep 15 2007 - Jun 15 2009

Taiwan

MSC :: Department of Ophthalmology

Publications

Tzu-Yu Chiu, Ming-Chieh Cheng, Yi-Hsuan Wei, Shu-Lang Liao
The role of lateral rectus muscle resection for severe esotropia after medial rectus muscle myectomy in Graves' ophthalmopathy. European journal of ophthalmology (2024)
Ying-Yi Chen, Yi-Hsuan Wei, Shu-Lang Liao
Postoperative residual vertical deviation affects quality of life in Asian patients with thyroid-associated ophthalmopathy (Graves ophthalmopathy). Japanese journal of ophthalmology (2023)
Yun Hsia, Chia-Chieh Hsiao, Yi-Hsuan Wei, I-Wen Lai, Chao-Wen Lin, Shu-Lang Liao
The Changes in Optic Nerve after Orbital Decompression Surgery for Thyroid Eye Disease and Case Reports of Ischemic Optic Neuropathy. BioMed research international 2022 (2022)
Anny M S Cheng, Yi-Hsuan Wei, Shu-Lang Liao
Strategies in Surgical Decompression for Thyroid Eye Disease. Oxidative medicine and cellular longevity 2020 (2020)
Cherng-Ru Hsu, Yen-Yi Chen, Ming Yao, Yi-Hsuan Wei, Yi-Ting Hsieh, Shu-Lang Liao
Orbital and ocular adnexal lymphoma: a review of epidemiology and prognostic factors in Taiwan. Eye (London, England) 35 (7) (2020)
Yun Hsia, Ching-Yuan Yeh, Yi-Hsuan Wei, Lily-Wei Chen, Shu-Lang Liao
Eyelid sebaceous carcinoma: Validation of the 8th edition of the American Joint Committee on cancer T staging system and the prognostic factors for local recurrence, nodal metastasis, and survival. Eye (London, England) 33 (6) (2019)